News

Cannabis History: William Brooke O’Shaughnessy: The Irish Cannabis Pioneer Who Changed Medicine Forever

In the history of medical advancements, a few figures stand out as transformative pioneers. Among them, William Brooke O’Shaughnessy is celebrated for introducing cannabis into modern medicine, setting the stage for today’s understanding and use of cannabinoid-based treatments. His groundbreaking research and clinical applications during the 19th century paved the way for contemporary movements advocating ...

November 21st, 2024|The Hive|

French Parkinson’s Patients Indicate Strong Support for Medical Cannabis and CBD Use

LOS ANGELES- A recent study published in Clinical Parkinsonism & Related Disorders reveals that a significant majority of individuals in France diagnosed with Parkinson's disease (PD) are in favor of utilizing medical cannabis and cannabidiol (CBD) for symptom management. The nationwide online survey, which included 1,136 participants with PD, found that 81.7% expressed support for ...

November 21st, 2024|Insights|

Distru Secures $6 Million Series A to Expand Cannabis ERP Leadership

LOS ANGELES- Distru, a enterprise resource planning (ERP) platform serving the cannabis industry, has successfully secured $6 million in a Series A funding round led by Poseidon Investment Management. This strategic investment aims to bolster Distru's expansion efforts and enhance its suite of products, reinforcing its position as a leading system-of-record for cannabis operators. Since ...

November 21st, 2024|Capital|

MAPS Wins FDA Approval for Clinical Trials of Medical Cannabis

SAN JOSE-- The U.S. Food and Drug Administration (FDA) Division of Psychiatry Products has cleared the Multidisciplinary Association for Psychedelic Studies (MAPS)’ Phase 2 study of smoked cannabis in Veterans for the treatment of PTSD (MJP2) to proceed. Initially placed on partial clinical hold by the FDA in 2021, MJP2 is a randomized, placebo-controlled study ...

November 20th, 2024|Business|

Curaleaf Secures Massachusetts’ First Cannabis Research License

LOS ANGELES- In a significant development for the cannabis industry, Curaleaf Holdings, Inc., a leading multistate operator, has secured Massachusetts' inaugural cannabis research facility license. The Massachusetts Cannabis Control Commission (CCC) unanimously approved the license for Curaleaf Processing, Inc., a subsidiary of Curaleaf, during its November 14, 2024, meeting. This license permits Curaleaf to operate ...

November 20th, 2024|Business|

Cybin Reports 79% Remission in MDD with CYB003, Prepares for Phase 3 Trials

LOS ANGELES- Cybin Inc., has announced promising results from its Phase 2 study of CYB003, a proprietary deuterated psilocybin analog developed for the treatment of major depressive disorder (MDD). The study demonstrated that 79% of patients achieved remission from depression symptoms six weeks after receiving two 12mg doses of CYB003. The trial also reported rapid ...

November 20th, 2024|Psychedelics|

Blunt Brunch Nationals: A Night of Glitz and Glam Celebrates Women in Cannabis

Las Vegas, NV – Blunt Brunch, a leading women’s empowerment organization in cannabis, is elevating its annual event to dazzling new heights. This year’s Blunt Brunch Nationals transforms from a traditional brunch into an elegant evening affair—a *Night of Glitz and Glam*—designed to celebrate the resilience, achievements, and contributions of women in the cannabis industry. ...

November 19th, 2024|Business|

GOP Senator Calls for Comprehensive Cannabis Reform, Criticizes Partial Measures

LOS ANGELES- In recent discussions on federal cannabis policy, several Republican senators have expressed diverse viewpoints regarding the regulation and legalization of cannabis. Senator Thom Tillis (R-NC) has advocated for treating cannabis similarly to tobacco, emphasizing the need for federal policies that allow a regulated market to develop. He stated, "I think we need to ...

November 19th, 2024|Justice|

Illinois Establishes Cannabis Research Institute to Advance Industry Understanding

LOS ANGELES- The State of Illinois, in collaboration with the City of Chicago, has inaugurated the Cannabis Research Institute (CRI), a joint initiative between the University of Illinois and the Discovery Partners Institute (DPI). This endeavor aims to enhance research and data collection on cannabis, informing future industry developments and public policy. Governor JB Pritzker ...

November 19th, 2024|Insights|

GetTangi Corporation Eyes Regulatory Opportunities in Cryptocurrency Under Trump Administration

LOS ANGELES- In the aftermath of Donald Trump’s re-election to the White House, Ronald Strauss, CEO of GetTangi Corporation, a company integrating cryptocurrency with legal cannabis transactions, expressed a measured outlook on the potential regulatory landscape for digital assets. Strauss, in a recent LinkedIn post, characterized Trump’s administration as possibly “transformative” for cryptocurrency, citing its ...

November 19th, 2024|Insights|

Robert F. Kennedy Jr. Nominated to Lead HHS, Poised to Drive Drug Policy Reforms

LOS ANGELES- President-elect Donald Trump has nominated Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services (HHS), positioning him to influence significant drug policy reforms, including the promotion of psychedelics therapy and the restructuring of federal cannabis regulations. Kennedy's journey to this nomination has been unconventional. He began the 2024 ...

November 18th, 2024|Insights|

What U.S. Employers Need to Know About Evolving Cannabis and Psychedelics Policies

LOS ANGELES- The November 5, 2024, elections have brought significant changes to state-level drug laws, requiring employers to reevaluate workplace policies, especially around cannabis and psychedelics. Key developments in Nebraska, Florida, North Dakota, South Dakota, and Massachusetts reflect the nation’s shifting but divided stance on drug legalization. Nebraska: A Step Forward for Medical Cannabis Nebraska ...

November 18th, 2024|Insights|

Week’s In Review: How Do You Target the Right SEC-Accredited Investors in Cannabis?; Amethyst Health Secures Conditional Medical Cannabis License in New York; California’s Cannabis Excise Tax Set to Increase Amid Industry Concerns

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it!  Cannabis Industry Highlights #1) How Do You Target the Right SEC-Accredited Investors in Cannabis?: It's ...

November 18th, 2024|Business, The Week in Review|

Trump’s Attorney General Pick Raises Hope for Cannabis Policy Reform

LOS ANGELES- President-elect Donald Trump has nominated Florida Representative Matt Gaetz as the next U.S. Attorney General, a move that could significantly influence federal cannabis policy. Gaetz, a vocal advocate for cannabis reform, has previously supported legislation aimed at reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. During his tenure ...

November 15th, 2024|Justice|

Amethyst Health Secures Conditional Medical Cannabis License in New York

LOS ANGELES- a partnership between Black Star Wellness, LLC, and AYR Wellness Inc, has been conditionally awarded a vertically integrated medical cannabis license by the New York Cannabis Control Board. This license grants the right to operate as a "Registered Organization" within New York's regulated cannabis market. Black Star Wellness holds a majority stake in ...

November 15th, 2024|Insights|

Psilocybin Shows Potential for OCD and Tourette’s Treatment, Study Finds

LOS ANGELES- A new study published in Molecular Psychiatry has identified psilocybin, a psychedelic compound, as a promising candidate for the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome. Conducted by researchers at the Hadassah-Hebrew University Medical Center, the study highlights the long-lasting therapeutic effects of psilocybin in preclinical trials using animal models. Led by ...

November 15th, 2024|Psychedelics|

AFC Gamma (AFCG) Set to Announce Quarterly Earnings

LOS ANGELES- AFC Gamma, Inc. is scheduled to release its quarterly earnings report on Wednesday, November 13, 2024, before the market opens.Analysts anticipate earnings of $0.33 per share for the quarter. In the previous quarter, AFC Gamma reported earnings of $0.54 per share, surpassing the consensus estimate of $0.49.The company's financial performance and strategic initiatives ...

November 14th, 2024|Business|

Italy’s Proposed Ban on Hemp Flower Sales Raises Industry Concerns

LOS ANGELES- Italy's "cannabis light" sector, which has experienced significant growth since the legalization of hemp in 2016, faces potential disruption due to proposed legislation aimed at banning products derived from hemp flowers. Prime Minister Giorgia Meloni's government contends that the existing law is overly permissive and seeks to eliminate the sale of hemp flower ...

November 14th, 2024|World|

Tech Pioneer James Clark Revives Eaze with $10M Investment

LOS ANGELES- James Clark, a tech industry veteran known for transformative ventures like Netscape, has turned his attention to the cannabis sector with a bold acquisition. In August, his firm FoundersJT LLC purchased the assets of Eaze Technologies, a leading cannabis delivery company, for $54 million, just weeks before Eaze had planned to shutter its ...

November 13th, 2024|Business|

Ireland’s Fianna Fáil Clarifies Stance on Drug Decriminalization: Focus on Cannabis, Excludes Hard Drugs

LOS ANGELES- Fianna Fáil has clarified its stance on drug decriminalization, specifying that its proposal to decriminalize possession for personal use applies exclusively to cannabis and excludes substances such as cocaine and heroin. This clarification follows the party's general election manifesto commitment to adopt a health-led approach to drug addiction, emphasizing treatment and education over ...

November 13th, 2024|World|

Idaho Activists File Cannabis Decriminalization Measure for 2026 Ballot

LOS ANGELES- In a strategic move following the rejection of cannabis legalization measures in three states during the 2024 general election, Idaho advocacy group Kind Idaho has submitted a ballot initiative aimed at decriminalizing personal cannabis use for the 2026 election. The proposal, filed with the Idaho Secretary of State's office, seeks to exempt adults ...

November 13th, 2024|Justice|

LA County DA Launches Campaign to Educate Teens on Cannabis Risks

LOS ANGELES- Los Angeles County District Attorney's Office has initiated a public service campaign to educate youth and caregivers about the risks associated with modern cannabis products, which are significantly more potent than those available five decades ago. This initiative, launched on October 31, 2024, aims to promote healthier communities by raising awareness of the ...

November 12th, 2024|Insights|

Chicago Atlantic Real Estate Finance Reports Q3 2024 Financial Results

LOS ANGELES- Chicago Atlantic Real Estate Finance Inc. has released its financial results for the third quarter of 2024, highlighting key metrics and strategic developments. As of September 30, 2024, the company's loan portfolio stood at $362 million, encompassing 29 portfolio companies. The weighted average yield to maturity was reported at 18.3%, a slight decrease ...

November 12th, 2024|Business|

Medicinal Cannabis Companies Target Veterans with Social Media Promotions, Raising Ethical Concerns

LOS ANGELES- Recent reports indicate that medicinal cannabis companies are increasingly targeting veterans through social media platforms, promoting free products and subscription services. This marketing strategy aims to attract veterans by offering complimentary samples and ongoing product deliveries, leveraging social media's extensive reach to engage this demographic. Advocates argue that such promotions provide veterans with ...

November 12th, 2024|Brands|
Go to Top